Evaluation of a bileaflet aortic valve prosthesis before and after thrombolytic tissue plasminogen activator therapy by continuous wave Doppler ultrasound

被引:0
|
作者
Chapman, JV [1 ]
Bierig, SM [1 ]
Trask, RV [1 ]
机构
[1] Mem Med Ctr, Dept Cardiovasc Ultrasound, Springfield, IL 62781 USA
关键词
D O I
10.1016/S0894-7317(98)70028-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombotic obstruction of mechanical prosthetic valves is a frequently encountered cause of prosthetic valve dysfunction, which can result in stenosis and regurgitation.(1) We present a case of thrombotic obstruction of a bileaflet mechanical aortic valve prosthesis that resulted in severe stenosis and regurgitation. Considering the known risk factors associated with surgical and thrombolytic treatments, a decision was made to use tissue plasminogen activator therapy to relieve the burden of the thrombotic valvular obstruction. In this case review, we use continuous wave Doppler to demonstrate recovery of normal valve function despite suboptimal two-dimensional imaging.
引用
收藏
页码:478 / 479
页数:2
相关论文
共 50 条
  • [41] Portable continuous wave Doppler ultrasound for primary healthcare in South Africa: can the EUnetHTA Core Model guide evaluation before technology adoption?
    Debjani Mueller
    Robert C. Pattinson
    Tsakane M. Hlongwane
    Reinhard Busse
    Dimitra Panteli
    Cost Effectiveness and Resource Allocation, 19
  • [42] Portable continuous wave Doppler ultrasound for primary healthcare in South Africa: can the EUnetHTA Core Model guide evaluation before technology adoption?
    Mueller, Debjani
    Pattinson, Robert C.
    Hlongwane, Tsakane M.
    Busse, Reinhard
    Panteli, Dimitra
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2021, 19 (01)
  • [43] Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy - Angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy
    Goodman, SG
    Langer, A
    Ross, AM
    Wildermann, NM
    Barbagelata, A
    Sgarbossa, EB
    Wagner, GS
    Granger, CB
    Califf, RM
    Topol, EJ
    Simoons, ML
    Armstrong, PW
    CIRCULATION, 1998, 97 (05) : 444 - 450
  • [44] ACTIVATION OF COMPLEMENT AND KININ SYSTEMS AFTER THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - A COMPARISON BETWEEN STREPTOKINASE AND RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    AGOSTONI, A
    GARDINALI, M
    FRANGI, D
    CAFARO, C
    CONCIATO, L
    SPONZILLI, C
    SALVIONI, A
    CUGNO, M
    CICARDI, M
    CIRCULATION, 1994, 90 (06) : 2666 - 2670
  • [45] B- MODE ULTRASOUND GUIDED- EXTRACORPOREAL PULSED LOW-LEVEL FOCUSED DUAL FREQUENCY ULTRASOUND THROMBOLYTIC THERAPY OF EMBOLIC ARTERY ACCOMPANIED BY TISSUE PLASMINOGEN ACTIVATOR (TPA) - LOADED PLGA MICROSPHERES ADMINISTRATION
    Mehrad, H.
    Foletti, A.
    ATHEROSCLEROSIS, 2021, 331 : E263 - E263
  • [46] Ultrasound-targeted transfection of tissue-type plasminogen activator gene carried by albumin nanoparticles to dog myocardium to prevent thrombosis after heart mechanical valve replacement
    Ji, Jun
    Ji, Shang-Yi
    Yang, Jian-An
    He, Xia
    Yang, Xiao-Han
    Ling, Wen-Ping
    Chen, Xiao-Ling
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 : 2911 - 2919
  • [47] INCREASE OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN PLASMA AFTER THROMBOLYTIC THERAPY OF PATIENTS WITH MYOCARDIAL-INFARCTION - A RANDOMIZED, PLACEBO-CONTROLLED STUDY
    MUNKVAD, S
    GRAM, J
    JESPERSEN, J
    FIBRINOLYSIS, 1992, 6 (01) : 45 - 50
  • [48] POWER DOPPLER ULTRASOUND FINDINGS BEFORE AND AFTER FOCUSED EXTRACORPOREAL SHOCK WAVE THERAPY FOR ACHILLES TENDINOPATHY: A PILOT STUDY ON PAIN REDUCTION AND NEOVASCULARIZATION EFFECT
    Santamato, Andrea
    Beatrice, Raffaele
    Micello, Maria Francesca
    Fortunato, Francesca
    Panza, Francesco
    Bristogiannis, Christos
    Cleopazzo, Elsa
    Macarinl, Luca
    Picelli, Alessandro
    Baricich, Alessio
    Ranieri, Maurizio
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2019, 45 (05): : 1316 - 1323
  • [49] Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - An analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety of a new thrombolytic (ASSENT 2) studies
    Barbash, GI
    Birnbaum, Y
    Bogaerts, K
    Hudson, M
    Lesaffre, E
    Fu, YL
    Goodman, S
    Houbracken, K
    Munsters, K
    Granger, CB
    Pieper, K
    Califf, RM
    Topol, EJ
    Van de Werf, F
    CIRCULATION, 2001, 103 (07) : 954 - 960
  • [50] Thrombolytic therapy of prosthetic valve thrombosis with recombinant tissue plasminogen activator (rt-PA) in infancy and childhood [Thrombolyse an mechanischen herzklappenprothesen mit rekombinantem gewebe-plasminogen-aktivator (rt-PA) im säuglings- und kleinkindesalter]
    Serpi M.
    Schmidt K.G.
    Kreuz W.
    Bucsenez D.
    Springer W.
    Hagl S.
    Ulmer H.E.
    Zeitschrift für Kardiologie, 2001, 90 (3): : 191 - 196